MaxCyte (MXCT) has released an update.
MaxCyte, Inc., a leader in cell-engineering platform technologies, is slated to announce its financial outcomes for the second quarter of 2024 on August 6th, after the U.S. market closes. Post-release, the company will hold a conference call at 4:30 p.m. Eastern Time to discuss the results, with the option for investors to join online or access a live webcast on the MaxCyte website. MaxCyte’s continued dedication to advancing cell therapeutics and bioprocessing applications underscores its commitment to enhancing patient care through cellular innovation.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
